4.8 Review

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies

Related references

Note: Only part of the references are listed.
Review Oncology

Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review

Shaheen Khan et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Medicine, Research & Experimental

Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicity

Ugur Eskiocak et al.

JCI INSIGHT (2020)

Review Pharmacology & Pharmacy

Bispecific Antibodies in the Treatment of Hematologic Malignancies

Johannes Duell et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Review Immunology

Immunotherapy in pediatric B-cell acute lymphoblastic leukemia

Kirk D. Wyatt et al.

HUMAN IMMUNOLOGY (2019)

Article Medicine, Research & Experimental

Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies

Nathan D. Trinklein et al.

Review Oncology

Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow

Raoufeh Ahamadi-Fesharaki et al.

MOLECULAR THERAPY-ONCOLYTICS (2019)

Review Biotechnology & Applied Microbiology

Treatment of hematological malignancies with T cell redirected bispecific antibodies: current status and future needs

Laahn H. Foster et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2019)

Article Biochemistry & Molecular Biology

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

Laurent Gauthier et al.

Article Oncology

Anti-GPRC5D/CD3 Bispecific T-Cell-Redirecting Antibody for the Treatment of Multiple Myeloma

Tatsushi Kodama et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Review Biotechnology & Applied Microbiology

Bispecific antibodies: a mechanistic review of the pipeline

Aran F. Labrijn et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Cell Biology

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Review Biochemistry & Molecular Biology

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML

Peter Valent et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemical Research Methods

Engineering therapeutic bispecific antibodies using CrossMab technology

Christian Klein et al.

METHODS (2019)

Review Oncology

Immune checkpoint inhibitor-related myocarditis

Kazuko Tajiri et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Medicine, Research & Experimental

Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies

Thomas Van Blarcom et al.

Review Hematology

Bispecific antibody based therapeutics: Strengths and challenges

Archana Thakur et al.

BLOOD REVIEWS (2018)

Article Medicine, Research & Experimental

A Preclinical Population Pharmacokinetic Model for Anti-CD20/CD3 T-Cell-Dependent Bispecific Antibodies

Gregory Z. Ferl et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)

Article Nanoscience & Nanotechnology

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Haitao Pan et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)

Review Medicine, General & Internal

Chronic lymphocytic leukaemia

Michael Hallek et al.

LANCET (2018)

Review Oncology

Cytokine release syndrome

Alexander Shimabukuro-Vornhagen et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Article Pharmacology & Pharmacy

Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma

Youssef Hijazi et al.

CURRENT CLINICAL PHARMACOLOGY (2018)

Article Oncology

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy

Jarushka Naidoo et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Oncology

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma

Jeffrey S. Weber et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Review Medicine, General & Internal

Non-Hodgkin lymphoma

James O. Armitage et al.

LANCET (2017)

Review Medicine, Research & Experimental

The making of bispecific antibodies

Ulrich Brinkmann et al.

Article Biotechnology & Applied Microbiology

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies

Elie Dheilly et al.

MOLECULAR THERAPY (2017)

Article Medicine, General & Internal

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Hagop Kantarjian et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medicine, General & Internal

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

David Baker et al.

EBIOMEDICINE (2017)

Article Oncology

PATHOBIOLOGY AND DIAGNOSIS OF MULTIPLE MYELOMA

Kevin Brigle et al.

SEMINARS IN ONCOLOGY NURSING (2017)

Review Pharmacology & Pharmacy

Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia

Hanna A. Knaus et al.

CURRENT DRUG TARGETS (2017)

Review Oncology

Chronic lymphocytic leukaemia

Lydia Scarfo et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)

Review Immunology

Immunotherapeutic implications of IL-6 blockade for cytokine storm

Toshio Tanaka et al.

IMMUNOTHERAPY (2016)

Editorial Material Oncology

Bispecific T-Cell Engagers (BiTEs) as Treatment of B-Cell Lymphoma

Nicole C. Smits et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Review Chemistry, Multidisciplinary

Nanomedicine approaches in acute lymphoblastic leukemia

Andra-Sorina Tatar et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Review Oncology

Targeting B-cell non Hodgkin lymphoma: New and old tricks

Antonio Giovanni Solimandoa et al.

LEUKEMIA RESEARCH (2016)

Article Medicine, General & Internal

Adult Acute Lymphoblastic Leukemia

Shilpa Paul et al.

MAYO CLINIC PROCEEDINGS (2016)

Article Biochemistry & Molecular Biology

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

Tilman Schlothauer et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2016)

Article Biochemistry & Molecular Biology

Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies

Marco Ruella et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)

Review Hematology

Pathogenesis beyond the cancer clone(s) in multiple myeloma

Giada Bianchi et al.

BLOOD (2015)

Review Hematology

The double-edged sword: Neurotoxicity of chemotherapy

Rajiv S. Magge et al.

BLOOD REVIEWS (2015)

Article Oncology

FDA Approval: Blinatumomab

Donna Przepiorka et al.

CLINICAL CANCER RESEARCH (2015)

Review Pharmacology & Pharmacy

Bispecific antibodies

Roland E. Kontermann et al.

DRUG DISCOVERY TODAY (2015)

Editorial Material Biotechnology & Applied Microbiology

Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer

Julia Stieglmaier et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2015)

Review Immunology

Targeting B-cell maturation antigen in multiple myeloma

Yu-Tzu Tai et al.

IMMUNOTHERAPY (2015)

Review Immunology

Landscape of Tumor Antigens in T Cell Immunotherapy

Sadia Ilyas et al.

JOURNAL OF IMMUNOLOGY (2015)

Review Oncology

Acute Lymphoblastic Leukemia, Version 2.2015

Joseph C. Alvarnas et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)

Review Biochemistry & Molecular Biology

Alternative molecular formats and therapeutic applications for bispecific antibodies

Christoph Spiess et al.

MOLECULAR IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

Xiaojuan Liu et al.

NATURE MEDICINE (2015)

Article Cell Biology

Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies

Liping L. Sun et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Review Biotechnology & Applied Microbiology

Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics

Timo Rath et al.

CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)

Review Pediatrics

Toxicity management for patients receiving novel T-cell engaging therapies

David M. Barrett et al.

CURRENT OPINION IN PEDIATRICS (2014)

Article Multidisciplinary Sciences

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Niccolo Bolli et al.

NATURE COMMUNICATIONS (2014)

Review Hematology

Diagnosis and Subclassification of Acute Lymphoblastic Leukemia

Sabina Chiaretti et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2014)

Article Hematology

CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma

Lawrence G. Lum et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)

Article Oncology

Cancer statistics, 2013

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

Article Oncology

B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

Robert O. Carpenter et al.

CLINICAL CANCER RESEARCH (2013)

Article Multidisciplinary Sciences

Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange

Aran F. Labrijn et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Education, Scientific Disciplines

Novel clinical trials for pediatric leukemias: lessons learned from genomic analyses

Andrea Biondi et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)

Review Pharmacology & Pharmacy

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

Craig A. Portell et al.

CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2013)

Article Medicine, General & Internal

Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma

Johanna Atamaniuk et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Biochemistry & Molecular Biology

Plasma Half-life Extension of Small Recombinant Antibodies by Fusion to Immunoglobulin-binding Domains

Meike Hutt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Review Medicine, Research & Experimental

Molecular pathogenesis of chronic lymphocytic leukemia

Gianluca Gaidano et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Immunology

Retargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies

Stefanie Koristka et al.

JOURNAL OF IMMUNOLOGY (2012)

Review Medicine, Research & Experimental

CD19 as an attractive target for antibody-based therapy

Ohad Hammer

Article Multidisciplinary Sciences

DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes

Ofir Hakim et al.

NATURE (2012)

Review Pharmacology & Pharmacy

Blinatumomab: A historical perspective

Dirk Nagorsen et al.

PHARMACOLOGY & THERAPEUTICS (2012)

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

Article Multidisciplinary Sciences

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

Wolfgang Schaefer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Hematology

Prognostic factors in adult acute lymphoblastic leukaemia

Jacob M. Rowe

BRITISH JOURNAL OF HAEMATOLOGY (2010)

Article Biochemistry & Molecular Biology

CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis

Siddhartha Jaiswal et al.

Article Biochemistry & Molecular Biology

Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives

Roland Stork et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Ralf Bargou et al.

SCIENCE (2008)

Review Biochemistry & Molecular Biology

CD38 at the junction between prognostic marker and therapeutic target

Silvia Deaglio et al.

TRENDS IN MOLECULAR MEDICINE (2008)

Article Medicine, General & Internal

Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma

Robert A. Kyle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

International staging system for multiple myeloma

PR Greipp et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Immunology

BCMA is essential for the survival of long-lived bone marrow plasma cells

BP O'Connor et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

Article Multidisciplinary Sciences

Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction:: Manifestation of a dual activation threshold

M Faroudi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Medicine, General & Internal

Genomic aberrations and survival in chronic lymphocytic leukemia.

H Döhner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)